Baillie Gifford & Co
MRNA icon

Baillie Gifford & Co’s Moderna MRNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$610M Sell
22,094,124
-2,854,434
-11% -$78.8M 0.46% 41
2025
Q1
$707M Sell
24,948,558
-13,941,013
-36% -$395M 0.62% 34
2024
Q4
$1.62B Sell
38,889,571
-3,568,512
-8% -$148M 1.24% 22
2024
Q3
$2.84B Sell
42,458,083
-990,958
-2% -$66.2M 2.12% 15
2024
Q2
$5.16B Sell
43,449,041
-1,206,776
-3% -$143M 4.02% 4
2024
Q1
$4.76B Sell
44,655,817
-998,710
-2% -$106M 3.7% 5
2023
Q4
$4.54B Buy
45,654,527
+5,344
+0% +$531K 3.6% 7
2023
Q3
$4.72B Sell
45,649,183
-61,912
-0.1% -$6.39M 4.3% 5
2023
Q2
$5.55B Sell
45,711,095
-755,076
-2% -$91.7M 4.72% 4
2023
Q1
$7.14B Buy
46,466,171
+1,679,425
+4% +$258M 6.44% 2
2022
Q4
$8.04B Sell
44,786,746
-493,277
-1% -$88.6M 8.38% 1
2022
Q3
$5.35B Sell
45,280,023
-279,768
-0.6% -$33.1M 5.52% 2
2022
Q2
$6.51B Sell
45,559,791
-69,435
-0.2% -$9.92M 6.67% 1
2022
Q1
$7.86B Sell
45,629,226
-142,853
-0.3% -$24.6M 5.51% 2
2021
Q4
$11.6B Buy
45,772,079
+3,554,725
+8% +$903M 6.38% 1
2021
Q3
$16.2B Sell
42,217,354
-3,665,859
-8% -$1.41B 8.5% 1
2021
Q2
$10.8B Buy
45,883,213
+545,449
+1% +$128M 5.25% 1
2021
Q1
$5.94B Buy
45,337,764
+21,025,493
+86% +$2.75B 3.32% 7
2020
Q4
$2.54B Buy
24,312,271
+17,086,635
+236% +$1.79B 1.41% 15
2020
Q3
$511M Buy
7,225,636
+3,166,153
+78% +$224M 0.35% 57
2020
Q2
$261M Buy
4,059,483
+499,599
+14% +$32.1M 0.2% 83
2020
Q1
$107M Buy
3,559,884
+143,771
+4% +$4.31M 0.12% 99
2019
Q4
$66.8M Buy
3,416,113
+201,316
+6% +$3.94M 0.06% 113
2019
Q3
$51.2M Buy
3,214,797
+7,202
+0.2% +$115K 0.06% 120
2019
Q2
$47M Buy
3,207,595
+632,394
+25% +$9.26M 0.05% 126
2019
Q1
$52.4M Buy
2,575,201
+849,357
+49% +$17.3M 0.06% 120
2018
Q4
$26.4M Buy
+1,725,844
New +$26.4M 0.03% 139